Spectral Medical Inc.
TSX:EDT.TOMedical - Diagnostics & Research
-$0.02 today
- Market cap
- $306.00M
- Beta
- 0.23
- P/E (TTM)
- -10.5
- EPS (TTM)
- -$0.13
Volume 0.02M
Average 0.06M
Returns on capital
Spectral Medical Inc. management
Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.
Return Metrics
ROE, ROIC & ROA over time
ROE
68.4%
avg 96.3%
ROIC
26.8%
avg -53.3%
ROA
-781.8%
avg -198.5%
Analysis
ROE is currently the strongest return metric at 68.4% versus its period average of 96.3%. 2 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Leadership
Who runs the company?
Review the executive team, tenure, compensation, and ownership.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|
Christopher Seto | Chief Executive Officer, Interim Chief Financial Officer & Director | CAD 483K | — | — | — |
John A. Kellum | Chief Medical Officer | CAD 472.03K | — | — | — |
Compensation is shown in the reported currency; data updated Nov 7, 2026.
Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK.
Insider trading
Are insiders buying or selling?
Follow recent insider purchases and sales reported on Form 4.
Insider Trading
SEC Form 4 transactions — last 12 months
No open-market purchases or sales in the last 12 months.
Growth analysis
Is management growing the business?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | +13.6% | +141.1% (5yr)1 analysts |
| Net Income | N/A | N/A | N/A | N/A1 analysts |
| EBIT | N/A | N/A | N/A | N/A1 analysts |
Analysis
Recent growth has been strongest in Revenue at +13.6% over three years. Forward estimates point to Revenue at +141.1% (5yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Who does Spectral Medical Inc. compete with?
Open similar companies to compare how their management teams allocate capital.
Questions
Management questions
Common questions about EDT.TO's management, answered from reported figures.
Who manages EDT.TO?
Spectral Medical Inc. (EDT.TO) lists 2 active executives. The top listed executive is John A. Kellum, Chief Medical Officer.
Continue the stock analysis
Jump to another research area for this company.